October 10, 2012 / M2 PRESSWIRE / BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Wednesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Wednesday there were 3965 companies with "abnormal" market making, 2017 companies with positive Friction Factors and 3341 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage gain per share Wednesday and low price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Pure Bioscience (NASDAQ:PURE), Zoom Technologies Inc (NASDAQ:ZOOM), Chelsea Therapeutics International Ltd (NASDAQ:CHTP), CytoDyn Inc (OTC:CYDY), Save The World Air Inc (OTCBB:ZERO), Bridgeline Digital Inc (NASDAQ:BLIN). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

  Symbol  Change    Percent   Buy Volume   Buy %%    Sell Volume  Sell %%   Net Volume   Friction
  PURE    $0.170    15.60%    560,668      69.90%    234,820      29.28%    325,848      19,168  
  ZOOM    $0.110    12.36%    174,065      74.88%    58,400       25.12%    115,665      10,515  
  CHTP    $0.110    9.73%     306,803      54.16%    258,548      45.64%    48,255       4,387   
  CYDY    $0.210    13.21%    41,014       37.73%    28,100       25.85%    12,914       615     
  ZERO    $0.120    9.76%     373,941      44.50%    343,089      40.83%    30,852       2,571   
  BLIN    $0.180    13.64%    144,904      62.07%    88,556       37.93%    56,348       3,130

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net buy volumes (buy volume, sell volume) and low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows PURE with a dollar gain Wednesday of $0.17000 and a Friction Factor of 19,168 shares. That means that it only took 19,168 more shares of buying than selling to move PURE higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Pure Bioscience (NASDAQ:PURE) - Pure Bioscience, Inc. engages in the development and commercialization of bioscience technologies principally in the United States. The company offers silver dihydrogen citrate (SDC) based antimicrobials. The silver dihydrogen citrate technology is an electrolytically generated source of stabilized ionic silver that could serve as the basis for various products in diverse markets. It also produces SDC as an active pharmaceutical ingredient, which is in clinical trials for multiple indications. In addition, the company provides Axen and Axen30 hard surface disinfectant products for commercial, industrial, and consumer applications, including restaurants, homes, and medical facilities; Axen50 food contact surface sanitizer for sanitization of food contact surfaces and equipment in environments, such as farms, food processing plants, schools, hospitals, restaurants, and homes; and SDC3A disinfectant and food contact surface sanitizer. In addition, it offers SDC-based antimicrobial product; and concentrated SDC-based water treatment product. Pure Bioscience, Inc. sells its products through partners and distributors primarily to industrial and consumer markets. The company was formerly known as Innovative Medical Services and changed its name to Pure Bioscience, Inc. Pure Bioscience, Inc. was founded in 1992 and is headquartered in El Cajon, California..

Zoom Technologies Inc (NASDAQ:ZOOM) - Zoom Technologies, Inc., through its subsidiaries, operates as a technology company that engages in electronic and telecommunication product design, development, and manufacturing. The company provides electronic manufacturing services (EMS) for original equipment manufacturer (OEM) customers, as well as involves in the design and production of mobile phone products. It develops and produces GSM and CDMA mobile phones, wireless telecommunication modules, digital cameras, cable TV set-top boxes, and GPS equipment. The company also develops various mobile phones and smart-phones based on TD-SCDMA, GSM, WCDMA, and CDMA technologies. It markets its mobile phone products through retail distributors in the Peoples Republic of China, as well as supplies GSM and CDMA mobile phones directly to customers. The company was founded in 1999 and is headquartered in Beijing, the People's Republic of China..

Chelsea Therapeutics International Ltd (NASDAQ:CHTP) - Chelsea Therapeutics International, Ltd., a development stage pharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of various human diseases. The companys compounds target various prevalent medical conditions, primarily rheumatoid arthritis, psoriasis, cancer, other immunological disorders, and neurogenic orthostatic hypotension associated with Parkinsons disease and other autonomic disorders. It offers Droxidopa, an orally active synthetic precursor of norepinephrine for the treatment of symptomatic neurogenic orthostatic hypotension, freezing gait in Parkinsons disease, and intradialytic hypotension in Japan. The company develops droxidopa in three indications, such as neurogenic orthostatic hypotension, intradialytic hypotension, and fibromyalgia. It also develops a portfolio of molecules for the treatment of various autoimmune/inflammatory diseases, such as a portfolio of metabolically inert antifolate molecules, including CH-1504 for the treatment of rheumatoid arthritis that is in a phase II head-to-head clinical trial; and CH-4051, which completed the phase I study designed to determine the maximum tolerated dose based on results of single-ascending and multiple-ascending dose evaluations. In addition, the company develops antifolate program, a platform consisting of a portfolio of dihydroorotate dehydrogenase(DHODH), inhibiting compounds known as the I-3D portfolio, a group of orally active compounds that inhibit the enzyme DHODH for the treatment of autoimmune diseases and transplant rejection. Chelsea Therapeutics International, Ltd. was founded in 2002 and is headquartered in Charlotte, North Carolina..

CytoDyn Inc (OTC:CYDY) - CytoDyn, Inc., a development stage biotechnology company, discovers and develops therapeutic monoclonal antibodies to address the medical needs in the areas of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). It engages in developing Cytolin that treats HIV/AIDS by preventing killer T cells from destroying the CD4 T cells in humans infected with HIV, which result in a suppression of the immune system. The company was founded in 1994 and is based in Santa Fe, New Mexico..

Save The World Air Inc (OTCBB:ZERO) - Save The World Air, Inc. engages in developing technology focused on energy efficiency of large-scale energy production and fuel economy for diesel fleets. It designs, develops, and licenses products to reduce operational costs for oil pipelines, and improve fuel economy and reduce emissions from diesel-powered internal combustion engines. The company has various patented and patent pending technologies, including AOT (Applied Oil Technology), under development with Temple University; and ELEKTRA (for diesel engine efficiency). Its AOT and ELEKTRA technologies use electric fields to alter some physical properties of petrochemical fluids to reduce viscosity of the fluids. The companys AOT products are intended to reduce the viscosity of crude oil, thereby making it less restrictive to pipeline transport and are marketed primarily to pipeline operators, as well as to pilot and government mandated delivery programs. Its ELEKTRA products are intended to increase fuel efficiency and reduce emissions, and are marketed primarily to specialty consumer accessories market for various types of diesel-fueled vehicles, including trucks, trains, maritime, military, and aviation. The company was formerly known as Mandalay Capital Corporation and changed its name to Save The World Air, Inc. in February 1999. Save The World Air, Inc. was founded in 1998 and is based in Santa Barbara, California..

Bridgeline Digital Inc (NASDAQ:BLIN) - Bridgeline Digital, Inc. operates as a developer of Web application management software and interactive business technology solutions that help organizations optimize business processes. Its iAPPS Product Suite is a software-as-a-service solution that unifies content management, analytics, e-commerce, and e-marketing capabilities enabling business users to swiftly enhance and optimize the value of their Web properties. The company helps customers to maximize the value of their rapidly changing Web applications with interactive technology services by Microsoft Gold Certified development teams. It specializes in Web application development, usability engineering, SharePoint development, rich media development, and search engine optimization. The company was formerly known as Bridgeline Software, Inc. and changed its name to Bridgeline Digital, Inc. in March 2010. Bridgeline Digital, Inc. was founded in 2000 and is based in Woburn, Massachusetts..

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net